肝性脑病患者短期预后的相关危险因素分析

王丰姣; 柳明江; 吴瑞红; 牛俊奇

doi:10.3969/j.issn.1001-5256.2017.04.022

肝性脑病患者短期预后的相关危险因素分析

DOI: 10.3969/j.issn.1001-5256.2017.04.022

1. 吉林大学第一医院肝胆胰内科
2. 吉林大学第一医院肝胆胰外科

详细信息

中图分类号: R575.3
计量
- 文章访问数: 2098
- HTML全文浏览量: 32
- PDF下载量: 481
- 被引次数: 0
出版历程
- 收稿日期: 2017-01-16
- 出版日期: 2017-04-20

A multivariate logistic regression analysis of short-term prognosis of patients with hepatic encephalopathy

Department of Hepatology, The First Hospital of Jilin University

摘要

摘要:
目的探讨肝性脑病（HE）患者短期预后相关的危险因素。方法回顾性分析2013年1月-2015年12月于吉林大学第一医院住院治疗的316例HE患者的临床资料,根据预后分为生存组（n=229）与死亡组（n=87）。将患者基础资料及生化指标进行单因素及多因素分析,筛选影响HE预后的危险因素。计量资料2组间比较采用t检验或Mann-Whitney U检验,计数资料2组间比较采用χ2检验。将单因素分析中有统计学意义的变量进一步行多因素logistic回归分析。结果 316例患者的男女比例为1.72∶1,45岁及以上患者269例（85.13%）。单因素分析结果显示年龄、合并原发性肝癌、HE分期、WBC、中性粒细胞、Hb、PLT、国际标准化比值、PT、PTA、尿素氮、肌酐、血清钠、血清钾、ALT、AST、GGT、Alb、IBil、TBil、前白蛋白在2组之间差异均有统计学意义（P值均<0.05）。多因素logistic回归分析结果显示合并原发性肝癌[比值比（OR）=3.278,95%可信区间（95%CI）:1.4947.194,P=0.003]、HE分...
- 肝性脑病 /
- 预后 /
- 危险因素
Abstract:
Objective To investigate the risk factors for poor short-term prognosis of patients with hepatic encephalopathy (HE) .Methods A retrospective analysis was performed for the clinical data of 316 patients with HE who were hospitalized and treated in The First Hospital of Jilin University from January 2013 to December 2015, and according to their prognosis, they were divided into survival group (229patients) and death group (87 patients) .The univariate and multivariate analyses were performed for their general data and biochemical parameters to screen out the risk factors for poor prognosis of HE.The t-test or Mann-Whitney U test was used for comparison of continuous data between groups, and the chi-square test was used for comparison of categorical data between groups.The multivariate logistic regression analysis was performed for the variables with statistical significance identified in the univariate analysis.Results All the patients were followed up for 30 days, and 87 patients died, resulting in a mortality rate of 27.5%.The male/female ratio was 1.72∶ 1, and 269 patients (85.13%) were aged ≥45 years.The univariate analysis showed that there were significant differences between the two groups in age, a combination of primary liver cancer, HE stage, white blood cell count, neutrophil count, hemoglobin, platelet count, international normalized ratio, prothrombin time, prothrombin time activity (PTA) , blood urea nitrogen, creatinine, serum sodium, serum potassium, alanine aminotransferase, aspartate aminotransferase, gamma-glutamyl transpeptidase, albumin, indirect bilirubin, total bilirubin (TBil) , and prealbumin (all P<0.05) .The multivariate analysis showed that a combination of primary liver cancer (OR=3.278, 95% CI: 1.494-7.194, P=0.003) , HE stage (OR=2.402, 95% CI: 1.711-3.372, P<0.001) , PTA (OR=0.969, 95% CI:0.951-0.988, P=0.001) , serum sodium (OR=0.956, 95% CI: 0.922-0.992, P=0.018) , and TBil (OR=1.004, 95% CI:1.003-1.006, P<0.001) were independent risk factors for the prognosis of patients with HE.Conclusion A combination of primary liver cancer, advanced HE stage, low serum sodium, low PTA, and increased TBil are independent risk factors for poor prognosis of HE, and the equation based on these indices has a certain reference value in clinical practice.
- hepatic encephalopathy /
- prognosis /
- risk factors

HTML全文

参考文献(16)

[1]VOLK ML, TOCCO RS, BAZICK J, et al.Hospital readmissions among patients with decompensated cirrhosis[J].Am J Gastroenterol, 2012, 107 (2) :247-252.

[2]BUSTAMANTE J, RIMOLA A, VENTURA PJ, et al.Prognostic significance of hepatic encephalopathy in patients with cirrhosis[J].J Hepatol, 1999, 30 (5) :890-895.

[3]Chinese Society of Gastroenterology and Chinese Seciety of Hepatology, Chinese Medical Association.Consensus on the diagnosis and treatment of hepatic encephalopathy in China (Chongqing, 2013) [J/CD].Chin J Front Med Sci:Electronic Version, 2014, 6 (2) :81-93. (in Chinese) 中华医学会肝病学会会, 中华医学会消化学分会.中国肝性脑病诊治共识意见 (2013年, 重庆) [J/CD].中国医学前沿杂志:电子版, 2014, 6 (2) :81-93.

[4]YU YH, JIANG JN, WU JZ, et al.Prognostic factors for patients with hepatic encephalopathy:a logistic regression analysis[J].Chin J Infect Dis, 2009, 27 (5) :305-307. (in Chinese) 玉艳红, 江建宁, 吴继周, 等.肝性脑病患者预后影响因素的Logistic回归分析[J].中华传染病杂志, 2009, 27 (5) :305-307.

[5]CUI YP, LI QF, LI QY, et al.Logistic regression analysis of prognostic risk factors for hepatic encephalopathy[J].J Clin Hepatol, 2016, 32 (1) :135-138. (in Chinese) 崔燕平, 李庆方, 李庆彦, 等.肝硬脑病患者的预后影响因素分析[J].临床肝胆病杂志, 2016, 32 (1) :135-138.

[6]WONG PY, XIA V, IMAGAWA DK, et al.Clinical presentation of hepatocellular carcinoma (PLC) in Asian-Americans versus nonAsian-Americans[J].Immigr Minor Health, 2011, 13 (5) :842-848.

[7]KIM WR, BIGGINS SW, KREMERS WK, et al.Hyponatremia and mortality among patients on the liver-transplant waiting list[J].N Engl J Med, 2008, 359 (10) :1018-1026.

[8]GUEVARA M, BACCARO ME, TORRE A, et al.Hyponatremia is a risk factor of hepatic encephalopathy in patients with cirrhosis:a prospective study with time-dependent analysis[J].Am J Gastroenterol, 2009, 104 (6) :1382-1389.

[9]CICHOZ-LACH H, MICHALAK A.Current pathogenetic aspects of hepatic encephalopathy and noncirrhotic hyperammonemic encephalopathy[J].World J Gastroenterol, 2013, 19 (1) :26-34.

[10]CORDOBA J, VENTURA-COTS M, SIMN-TALERO M, et al.Characteristics, risk factors, and mortality of cirrhotic patients hospitalized for hepatic encephalopathy with and without acute-on-chronic liver failure (ACLF) [J].Hepatol, 2014, 60 (2) :275-281.

[11]UDAYAKUMAR N, SUBRAMANIAM K, UMASHANKAR L, et al.Predictors of mortality in hepatic encephalopathy in acute and chronic liver disease:a preliminary observation[J].Clin Gastroenterol, 2007, 41 (10) :922-926.

[12]SHARMA P, AGRAWAL A, SHARMA BC, et al.Prophylaxis of hepatic encephalopathy in acute variceal bleed:a randomized controlled trial of lactulose versus no lactulose[J].Gastroenterol Hepatol, 2011, 26 (6) :996-1003.

[13]AN H, JANG J, BAE S, et al.Serum C-reactive protein is a useful biomarker for predicting outcomes after liver transplantation in patients with hepatocellular carcinoma[J].Liver Transpl, 2012, 18 (12) :1406-1414.

[14]PAPP M, VITALIS Z, ALTORJAY I, et al.Acute phase proteins in the diagnosis and prediction of cirrhosis associated bacterial infections[J].Liver Int, 2012, 32 (4) :603-611.

[15]WONG F, BERNARDI M, BALK R, et al.Sepsis in cirrhosis:report on the 7th meeting of the International Ascites Club[J].Gut, 2005, 54 (5) :718-725.

[16]FERNNDEZ J, GUSTOT T.Management of bacterial infections in cirrhosis[J].Hepatol, 2012, 56 (1) :1-12.

施引文献

资源附件(0)

访问统计